Intrathecal therapy offers several benefits, including the direct delivery of high drug concentrations to the CNS, which can improve treatment outcomes for CNS-involved cancers. It also reduces systemic exposure to chemotherapy, potentially decreasing systemic side effects. This targeted approach can be crucial in managing and controlling CNS metastases, ultimately improving the quality of life for cancer patients.
